Log in

Relevant bibliographies by topics / Glycogen storage disease type III / Books

To see the other types of publications on this topic, follow the link: Glycogen storage disease type III.

Books on the topic 'Glycogen storage disease type III'

Author: Grafiati

Published: 14 December 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 18 books for your research on the topic 'Glycogen storage disease type III.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Filosto, Massimiliano. Advances in diagnosis and management of glycogenosis II. Hauppauge, N.Y: Nova Science Publishers, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Crowley, John F. Chasing miracles: The Crowley family journey of strength, hope, and joy. New York: Newmarket Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Anand, Geeta. The Cure. New York: HarperCollins, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Toscano, Antonio, Massimiliano Filosto, and Alessandro Padovani. Advances in Diagnosis and Management of Glycogenosis II. Nova Science Publishers, Incorporated, 2013.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

van der Ploeg, Ans T., and Pascal Laforêt. Pompe Disease. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0055.

Full text

Abstract:

Pompe disease, also named acid maltase deficiency and glycogen storage disease type II (GSDII), is a rare autosomal recessive disorder caused by the deficiency of the glycogen-degrading lysosomal enzyme acid α‎-glucosidase. The clinical spectrum of this disease is broad, varying from a lethal infantile-onset generalized myopathy including cardiomyopathy, to late-onset slowly progressive muscle weakness mimicking limb-girdle muscular dystrophy. Respiratory insufficiency is a frequent complication and the main cause of death. The prognosis of Pompe disease has changed considerably with the use of enzyme replacement therapy using recombinant acid α‎-glucosidase (alglucosidase alfa), which has been widely available since 2006. Improvements in survival and major motor achievements can be observed in patients with infantile forms, and recent studies demonstrate improvement of walking distance and stabilization of pulmonary function in late-onset forms. A longer-term study of the safety and efficacy of ERT, based on data gathering across the complete spectrum of Pompe disease via national or international patient registries, is needed in order to formulate more precise guidelines for treatment.

APA, Harvard, Vancouver, ISO, and other styles

6

Anand, Geeta. The Cure: How a Father Raised $100 Million--And Bucked the Medical Establishment--In a Quest to Save His Children. William Morrow, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Anand, Geeta. The Cure: How a Father Raised $100 Million--And Bucked the Medical Establishment--In a Quest to Save His Children. William Morrow, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Anand, Geeta. Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Anand, Geeta. Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Anand, Geeta. Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Anand, Geeta. Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Anand, Geeta. Cure: How a Father Raised $100 Million--And Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Anand, Geeta. Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. HarperCollins Publishers, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Anand, Geeta. The Cure: How a Father Raised $100 Million--and Bucked the Medical Establishment--in a Quest to Save His Children. Harper Paperbacks, 2009.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Cassiman, David, Pascal Laforêt, and Fanny Mochel. Glycogen Storage Disorders. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199972135.003.0001.

Full text

Abstract:

Glucose is the body’s major energy source, and carbohydrate serves as fuel—particularly during high-intensity exercise that requires rapid energy release. A deficiency of any of the enzymes involved in the catabolism of glycogen to glucose may cause symptoms, with hypoglycemia and exercise intolerance as the most common presentations. Glycogen storage disorders (GSD) affect muscle, liver, and brain. The most common GSDs affecting muscle are GSD II (Pompe disease) and GSD V (McArdle disease). GSDs affecting mainly the liver are GSD I, III, IV, VI, IX, XI. Most liver-GSDs present during infancy, with symptoms of hypoglycemia, impressive hepatomegaly, and retarded growth. Adult presentations have been reported for GSD Ia, III, IV, and IX.Adult polyglucosan body disease (APBD) is the main GSD affecting primarily the brain and mainly characterized by spastic paraplegia, axonal neuropathy and leukodystrophy. APBD is a subtype of GSD IV and is due to a deficiency of glycogen branching enzyme (GBE). Besides GSD IV, other GSDs have been reported to have CNS effects in some patients—notably GSD II and GSD III.

APA, Harvard, Vancouver, ISO, and other styles

16

Burtis, Quentin. Coloring Book - You Will Get Better - Glycogen Storage Disease Type II. Independently Published, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jr, Thomas Fraites. Muscle-directed Gene and Enzyme Replacement Therapies for Glycogen Storage Disorder Type II Pompe Disease. Dissertation Discovery Company, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Jr, Thomas Fraites. Muscle-directed Gene and Enzyme Replacement Therapies for Glycogen Storage Disorder Type II Pompe Disease. Dissertation Discovery Company, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!